SerraTrolTM provides a very unique proteolytic enzyme (protein digesting) called serrapeptidase (pharmaceutical designation serratiopeptidase). Serrapeptidase has been used as a non-steroidal anti-inflammatory agent by physicians in various settings. This enzyme was originally produced by silk worms. Clinical investigations show its ability to support the breakdown of plaque buildup that accumulates in arterial walls. Likewise, serrapeptidase breaks down "non-living" tissue, such as scar tissue and blood clots.
Serrapeptidase not only supports inflammation relief it also promotes pain relief by inhibiting the release of pain-inducing amines from inflamed tissues. Health professionals all over Europe and Asia have recognized the inflammatory and pain relief properties of serrapeptidase and are using it as an alternative to NSAIDs. Furthermore, serrapeptidase has also shown in clinical trails to reduce viscosity of sputum indicating additional benefits in respiratory health and those with allergies by breaking down the virus laden mucus allowing it to be expelled out of the lungs through coughing.
A 1990 study conducted by the Institute of Clinical Otorhinolaryngology at the University of Naples, Italy, evaluated serrapeptidase in acute or chronic inflammation of otorhinolaryngology pathology. The efficacy and tolerability of serrapeptidase were evaluated in a multicentre, double-blind, placebo-controlled study of 193 subjects suffering from acute or chronic ear, nose or throat disorders. Treatment lasted 7-8 days, with the drug or placebo being administered at a rate of two tablets three times a day. After 3-4 days of treatment, significant symptom regression was observed in peptidase-treated patients. There was also a significant reduction in symptoms after 7-8 days for patients in both treatment groups but the response was more marked in those patients receiving the active drug. Statistical comparison between the two groups confirmed the greater efficacy and rapid action of the peptidase against all the symptoms examined at both stages. Tolerance was found to be very good and similar for both groups. It was concluded that serrapeptidase has anti-inflammatory, anti-oedemic and fibrinolytic activity and acts rapidly on localized inflammation.
Serratiopeptidase is believed to work by breaking down insoluble protein by-products of blood coagulation known as fibrin. It also thins the fluids from inflammation or injury and facilitates their damage which speeds the tissue repair process. In Germany and other European countries, serrapeptidase is commonly used to support inflammation and swelling due to trauma. Much of the research that exists on serrapeptidase is of European origin. One double-blind study conducted by German researchers involved 66 subjects that had surgery to fix a ruptured lateral collateral ligament of the knee. On the third day post operative procedures, the group received serratiopeptidase and saw a significant reduction in swelling more rapidly than the control group. The subjects receiving serrapeptidase reported less pain more quickly than the control group. As for cardiovascular effects, serratiopeptidase has shown the ability to breakdown dead or damaged tissue without harming live tissue. Plaque build up can be slowly dissolved without hurting the arterial walls.
Serrapeptidase has a long history of safe and effective use in Europe and Japan. Due to its limited reports of side effects and anti-inflammatory capabilities, serrapeptidase is a logical alternative to potentially harmful NSAIDs. Researchers have taken a bib step towards finding relief for individuals dealing with inflammatory complications. Even though it is considered very safe, there is caution to be taken due to the enzyme’s powerful activity. Gastrointestinal irritation may occur in the elderly with chronic long term use. It is very rare but has been reported. Also a very rare occasion but has been reported is a susceptibility to increased lung infections due to seratiopeptidases ability to thinning mucous secretions. This is mostly a benefit but individuals with a history of lung conditions should seek professional advice before taking this enzyme.
MRM offers to great options for consumers purchasing SerraTrol. This high-quality supplement comes in both 5mg and 10mg enteric coated tablets. Studies have shown that a daily dose of 10mg provides remarkable benefits to individuals that wish to promote joint health, strengthen capillaries, relieve allergy symptoms and support respiratory and arterial health.